A person may wonder whether there is enough medication remaining, whether the counter returned to the expected position, or why liquid appears to remain after the final planned dose
Duration Guidelines Based on Clinical Evidence Current medical guidelines recommend continuing GLP-1 therapy indefinitely for patients with obesity or weight-related metabolic conditions, similar to how blood pressure or cholesterol medications are managed long-term
Previous studies reporting that GLP-1-based agents suppress microglial activation, inhibit NF-B signalling, and reduce mitochondrial stress [36], further support the notion that Retatrutide may alleviate inflammatory burden, particularly through modulation of TNF-
These sensations can closely mimic diverticulitis symptoms, making it difficult to tell whether discomfort is medication-related or something more serious
However, persistent or severe headaches should be medically assessed